The Prostate Cancer Clinical Trials Consortium: Clinical Research Site Application

Abstract

Purpose: The purpose of the PCCTC is to accelerate the development of novel therapeutics for prostate cancer patients, both by bringing own areas of expertise and contributing substantially to the activity of the consortium in the areas of biomarker development, androgen receptor targeted therapies, aggressive variant/neuroendocrine prostate cancer, and theranostics/novel molecular imaging. Results: During the reporting period, 28 patients were accrued across six PCCTC clinical trials, including two trials led by UCSF. Two UCSF-led LOIs have been submitted, including a trial of PSMA-directed SBRT trial in oligometastatic CRPC presented at the Scientific Oversight Committee in October 2019 and an additional immunotherapy trial with combination of pembrolizumab plus talabostat.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2020
Accession Number
AD1125847

Entities

People

  • Rahul Aggarwal

Organizations

  • University of California, San Francisco

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Androgen Receptors
  • Androgens
  • Biological Markers
  • Biomedical Research
  • California
  • Cancer
  • Clinical Trials
  • Consortiums
  • Data Analysis
  • Department Of Defense
  • Detection
  • Diseases And Disorders
  • Infrastructure
  • Medical Personnel
  • Neoplasms
  • Nuclear Medicine
  • Oncology
  • Prostate
  • Prostate Cancer
  • Radiosurgery
  • Teamwork
  • Therapy
  • Tissues

Fields of Study

  • Medicine
  • Physics

Readers

  • Oncology
  • Prostate Cancer Biology.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech